PHVS
Pharvaris N.V. · Healthcare · Market cap $2.0B(Price slightly stale)
Insiders sold $20.5M net in the last 90 days ·10 sellers, 0 buyers· 11 of 19 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 25, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$33.0M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Latest filing
Oct 13, 2026
Monges Viviane
Pharvaris N.V. (PHVS) has 55 SEC Form 4 filings (129 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Oct 13, 2026.
Inside the rolling window, 11 insiders at Pharvaris N.V. reported no open-market purchases and 53 open-market sales totaling $33.0M. The most active filer is President Lu Peng with 11 filings. Insiders have net sold $32.4M over the trailing 6 months. The most recent open-market filing is a sale of 11,969 shares by Director Monges Viviane, dated Sep 23, 2026, worth $396K.
- Industry:Biotechnology
- CEO:Berndt Modig
- Employees:148
- HQ:Zug, ZH, CH
- IPO:2021-02-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
Monges VivianeFirst in 4 months | Director | Sale | 11,969 | $396K | Sep 25 | -4.2% | SEC ↗ |
| Director | Sale | 800 | $29K | Sep 24 | -7.1% | SEC ↗ | |
Nassif David W.First in 4 months | CFO / CLO | Sale | 6,000 | $219K | Sep 23 | -7.3% | SEC ↗ |
Bjork ElisabethFirst in 4 months | Director | Sale | 52,500 | $2.0M | Sep 21 | -14.9% | SEC ↗ |
| Director | Sale | 14,493 | $559K | Sep 21 | -14.9% | SEC ↗ | |
| Chief Early Development | Sale | 20,000 | $765K | Sep 21 | -14.9% | SEC ↗ | |
| President | Sale | 100,000 | $3.5M | Sep 21 | -14.9% | SEC ↗ | |
| Director | Sale | 200,000 | $7.0M | Sep 21 | -14.9% | SEC ↗ | |
Abele Stefan AndreasFirst in 4 months | Chief Technical Ops Officer | Sale | 46,400 | $1.8M | Sep 17 | -19.3% | SEC ↗ |
| Director | Sale | 8,667 | $332K | Sep 17 | — | SEC ↗ | |
Souverijns WimFirst in 4 months | Chief Commercial Officer | Sale | 20,000 | $786K | Sep 16 | — | SEC ↗ |
Souverijns WimFirst in 4 months | Chief Commercial Officer | Sale | 6,090 | $237K | Sep 16 | — | SEC ↗ |
| President | Sale | 15,000 | $602K | Sep 15 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 2,291 | $90K | Sep 15 | — | SEC ↗ | |
| Chief Early Development | Sale | 30,000 | $1.1M | Sep 14 | — | SEC ↗ | |
Glassman RobertFirst in 4 months | Director | Sale | 8,000 | $300K | Sep 11 | — | SEC ↗ |
| President | Sale | 15,000 | $610K | Sep 9 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 2,292 | $80K | Aug 18 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 2,292 | $80K | Jul 15 | — | SEC ↗ | |
| Director | Sale | 9,288 | $326K | Jul 1 | — | SEC ↗ | |
| Director | Sale | 30,712 | $1.1M | Jul 1 | — | SEC ↗ | |
| Chief Early Development | Sale | 17,597 | $617K | Jul 1 | — | SEC ↗ | |
| Chief Early Development | Sale | 58,575 | $2.1M | Jul 1 | — | SEC ↗ | |
| Chief Early Development | Sale | 4,600 | $162K | Jun 29 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 15,000 | $519K | Jun 29 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does PHVS have?
Pharvaris N.V. (PHVS) has 55 SEC Form 4 filings (129 transaction rows) in the rolling 365-day window, disclosed by 11 distinct insiders. Most recent filing: Oct 13, 2026.
When was the most recent SEC Form 4 filing for PHVS?
The most recent Form 4 filing for PHVS on Tracefour is dated Oct 13, 2026.
Who is the most active insider at PHVS?
The most active SEC Form 4 filer at PHVS in the rolling window is President Lu Peng, with 11 filings.
What is the net insider flow at PHVS over the last 6 months?
Over the trailing 180 days, insiders at PHVS have net sold $32.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PHVS in the current window?
Inside the rolling window, insiders at PHVS bought $0 and sold $33.0M based on SEC Form 4 filings.
Can I get alerts for PHVS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Pharvaris N.V. (PHVS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Pharvaris N.V. is in the Healthcare sector.